Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Geriatric Oncology
|
January 14, 2025
Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303
Vicki A Morrison, Jennifer Le-Rademacher, Olivia Bobek, et al.
BJU International
|
May 12, 2026
Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial
Nancy Wei, Ryan M Phillips, Eugene Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)
Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
Leukemia & Lymphoma
|
July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201
Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Michael J Morris, Glenn Heller, David W Hillman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Geriatric Oncology
|
January 14, 2025
Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303
Vicki A Morrison, Jennifer Le-Rademacher, Olivia Bobek, et al.
BJU International
|
May 12, 2026
Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial
Nancy Wei, Ryan M Phillips, Eugene Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)
Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
Leukemia & Lymphoma
|
July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201
Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Michael J Morris, Glenn Heller, David W Hillman, et al.
Page
of 1